Diglifloz 5mg 30 tabs 6223003571320

Diglifloz 5mg 30 tabs 6223003571320

Description:

Diglifloz 5 mg film-coated tablets is an oral prescription antidiabetic medicine containing dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor. It is used as part of a comprehensive diabetes care plan to help control high blood sugar levels in adults with type 2 diabetes mellitus, usually in combination with diet and exercise, and often with other antidiabetic medications such as metformin. By promoting urinary glucose excretion, Diglifloz helps reduce blood glucose, improve glycemic control, and support long-term health prevention of diabetes-related complications.

Indications:

• Type 2 diabetes mellitus in adults as monotherapy when metformin is inappropriate due to intolerance or contraindication (e.g. renal impairment where metformin cannot be used, as per physician judgment).
• Type 2 diabetes mellitus in adults as add-on therapy to other glucose-lowering medicines (such as metformin, sulfonylureas, DPP-4 inhibitors, insulin) when these alone do not provide adequate glycemic control.
• Helps lower elevated fasting and postprandial blood glucose levels.
• Contributes to reduction in HbA1c (glycated hemoglobin), supporting long-term glycemic control.
• May assist in modest weight reduction and blood pressure lowering as part of overall diabetes management (as observed with SGLT2 inhibitors), under medical supervision.

Active Ingredients / Key Components:

• Dapagliflozin – 5 mg per film-coated tablet.
• Inactive ingredients/excipients: Full excipient list is not available in the provided data. Typical excipients may include tablet fillers, binders, coating agents, and stabilizers, but the exact composition is not specified and should be checked on the package insert.

Dosage & Administration / How to Use:

• Standard adult dose: 5 mg dapagliflozin (1 tablet) once daily, or as directed by the treating physician. The dose may be adjusted or increased to 10 mg daily according to clinical response and tolerability, following medical advice.
• Route of administration: Oral use only.
• How to take: Swallow the tablet whole with a sufficient amount of water. Do not crush, break, or chew the film-coated tablet unless your doctor or pharmacist specifically advises otherwise.
• With or without food: Diglifloz can be taken with or without food. Try to take it at the same time each day to help maintain consistent blood levels and improve adherence.
• Combination therapy: When used with insulin or insulin secretagogues (e.g. sulfonylureas), your doctor may reduce the dose of these agents to lower the risk of hypoglycemia.
• Missed dose: If you miss a dose, take it as soon as you remember on the same day. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not take a double dose to make up for a missed one.
• Duration of use: Long-term treatment as prescribed by your physician. Do not stop taking Diglifloz without consulting your healthcare provider, as this may worsen blood sugar control.
• Special populations: Dose adjustments or avoidance may be required in patients with renal or hepatic impairment, elderly patients, or those at risk of volume depletion. Use only under close medical supervision.

Clinical Benefits:

• Improves glycemic control in adults with type 2 diabetes by lowering fasting and postprandial blood glucose levels.
• Reduces HbA1c levels when used alone or in combination with other antidiabetic medications, supporting long-term diabetes management.
• Promotes urinary glucose excretion (glycosuria) by inhibiting SGLT2 in the kidneys, offering an insulin-independent mechanism of action.
• May contribute to modest weight reduction and slight blood pressure lowering as part of a comprehensive diabetes care plan, when combined with diet and exercise.
• Helps reduce the risk of long-term diabetes complications associated with poor glycemic control, such as cardiovascular, renal, and microvascular complications, when used as part of an overall treatment strategy guided by a physician.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to dapagliflozin or any of the excipients in the formulation.
• Not indicated for patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis (DKA). It may increase the risk of ketoacidosis, including euglycemic DKA.
• Use with caution in patients with moderate to severe renal impairment or end-stage renal disease. Efficacy is reduced in significant renal dysfunction and risk of adverse events may increase. Follow physician guidance and local product labeling.
• May increase the risk of genital mycotic infections (e.g. vulvovaginal candidiasis, balanitis) and urinary tract infections due to increased urinary glucose. Maintain good personal hygiene and report symptoms to your doctor.
• Can cause volume depletion, hypotension, or dizziness, especially in elderly patients, those on diuretics, or those with low blood pressure. Monitor blood pressure and hydration status.
• Use with caution in patients with a history of recurrent urinary tract infections, urosepsis, or pyelonephritis.
• Monitor renal function periodically, especially in patients with pre-existing kidney disease or those taking nephrotoxic medications.
• There have been reports of Fournier’s gangrene (necrotizing fasciitis of the perineum) with SGLT2 inhibitors. Seek immediate medical attention if you experience pain, redness, or swelling of the genital or perineal area along with fever or malaise.
• Consult your doctor before use if you are pregnant, planning to become pregnant, or breastfeeding. Dapagliflozin is generally not recommended during pregnancy and lactation unless clearly needed and prescribed by a specialist.
• Inform your doctor about all other medicines you are taking, especially diuretics, blood pressure medications, insulin, or other antidiabetic agents, to avoid interactions and hypoglycemia.
• Avoid excessive alcohol intake, as it may increase the risk of hypoglycemia or ketoacidosis.
• Consult your doctor before use if you have liver disease, low blood pressure, recurrent infections, or a history of ketoacidosis.
• Keep out of reach of children.
• Not intended to diagnose, treat, cure, or prevent any disease beyond its approved medical indications and physician guidance.

Side Effects:

• Common side effects: Increased urination, genital fungal infections (e.g. yeast infections), urinary tract infections, thirst, mild dehydration, and dyslipidemia (changes in blood lipids) in some patients.
• Less common side effects: Dizziness or lightheadedness (especially on standing), hypotension, rash, pruritus, or allergic reactions.
• Serious side effects (seek immediate medical attention): Signs of diabetic ketoacidosis (nausea, vomiting, abdominal pain, difficulty breathing, confusion, unusual fatigue), severe urinary tract infection (fever, flank pain, burning urination, blood in urine), severe genital pain or swelling, symptoms of Fournier’s gangrene, or severe allergic reactions (swelling of face, lips, tongue, throat, difficulty breathing).
• If you experience persistent or bothersome side effects, contact your doctor or pharmacist for advice and possible adjustment of therapy.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.

Specifications:

• Strength: 5 mg dapagliflozin per film-coated tablet.
• Form: Oral film-coated tablet.
• Pack size: 30 tablets per pack.
• Intended use: Prescription antidiabetic medicine for adults with type 2 diabetes mellitus, as directed by a healthcare professional.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.